We did an overlap analysis of our SCREEN-WELL® Neurotransmitter library (BML-2810) with our SCREEN-WELL® FDA-approved drug library (BML-2843) and there seems to be an overlap of about 11% (73 compounds out of 681). It means that at least 11% of the compounds are FDA-approved. We also went through each compound, submitted them to the FDA search engine, and found 110 compounds that are FDA-approved out of 681 supplied in this library (16%). There might be more but we do not currently have access to this information.